🎆The Landmark Trial series is back, where we highlight pivotal studies that have shaped VIR and hear directly from Principal Investigators! 🧠Dr. Jeffrey L. Saver will discuss leading the SWIFT-PRIME trial and its impact on stroke interventions. Register: https://t.co/RCSMWjN7oJ

Happening this Thursday!! Are you registered yet? Link below!

Original Article: Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension (BaxHTN phase 3 trial) https://t.co/iRVxdmp7Ss Editorial: Aldosterone Synthase Inhibition for Hypertension https://t.co/qAx3z4Iy7s #Cardiology

🚀 Big win for #ASCVD Prevention! The VESALIUS-CV Phase 3 trial fullfilled its primary endpoints: #evolocumab significantly reduced CVD events in high-risk patients without prior AMI or stroke. 💥💓 This is a major leap forward for primary prevention! https://t.co/IQCfhK8wV3

📣 Next Journal Club is here! 📣 🗓️ Wednesday, OCTOBER 1, 2025 ⏱️ 6 PST/9 EST Topic: Systemic Therapies in Unresectable Hepatocellular Carcinoma Trial: Yau et al 2025 Presented by: Dave Enriquez & Shiva Morisetty, MD Facilitated by: Dr. Joel Brothers Scan QR code for Zoom link!

ASSET-IT phase 3 trial: Guidelines recommend intravenous thrombolysis within 4.5 hours after onset of acute ischemic stroke, but vascular reocclusion may occur. Adjunct treatment with tirofiban might improve outcomes. Research findings are summarized in a new Quick Take video.

Dose and duration with DOACs for provoked would be good to review @tnvirjc @WCVISociety @WCVIS_Chicago @SIRRFS @cirsesociety @TraineesBSIR @IRJuniorsAUS

Original Article: Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO trial) https://t.co/Epe4Q957pV Editorial: Art within Evidence — Balancing Anticoagulant Duration in VTE Care https://t.co/IdJp3T20rM #Hematology

For those who read @VascularSVS @JVascSurg @EJVES_ESVS @SUNDAYtrial @EarnestTrial

🚀 PANTHER-2 Clopidogrel monotherapy is superior to aspirin monotherapy for MACCE prevention with no increase in the risk of bleeding in patients with established CAD #ESCCongress 💊 Online 👉 https://t.co/BxwmGa49bo @escardio @vlgmrc @TheLancet #Pharmacotherapy

📣Journal Club Alert📣 📅August 25th 2025📅 ⏰7 PM EST / 4 PM PST⏰ Topic: STRIDE Trial: Semaglutide and walking capacity for symptomatic PAD and T2DM patients Presented by: Desiree Duncan & @MichelleMDai Facilitated by: @VISLAMDSCAIP Scan QR to register

We are proud to announce that Vascular & Interventional is now an INDEPENDENT department at KP LAMC! Congrats to our chief Dr Ken Lam on this monumental achievement. This is yet another milestone in the continued evolution of EVIS as a distinct clinical and surgical specialty.

Love to see it. @KPVISLA pushing EVIS forward one medical student at a time 💪

That’s my PD 😤

🎯Get ready to ace your VIR sub-internship! Master more common consults like management of gastrointestinal bleeding, pulmonary embolisms, and uterine fibroids in our second prep session. Don't miss out! Register here: https://t.co/MLoXUtOI8F

Colorectal cancer liver disease management @cirsesociety @ETF_IRtrainees @TraineesBSIR @IR_Juniors @Road2IR @ISVIRIndia @J_CIRCLE_IVR

🧠Join us for a conversation with VIR physicians who’ve made neurointervention part of their practice. We’ll explore their unique journeys, what a day looks like with neuro procedures, and get advice for aspiring VIRs! Register here: https://t.co/EQqh1H3C8n

Happening this Wednesday! Register to receive your personalized Zoom link!

Reminder that our Acute Care Series talk on postpartum hemorrhage with Dr. Geronemus is tomorrow! Register using the link below! @AGeronemus @MiamiVasc

Mark your calendars for our next Match Series event, #VIR Resident Panel! Bring your questions and learn about clinical VIR training. Register here for your Zoom link: https://t.co/juVjObrPi4 #Match2026 #MedStudent #FutureRadRes #Surgery #IRad #IamIR